Abstract
The list of multiple endocrine neoplasias (MENs) that have been molecularly elucidated is growing with the most recent addition of Carney complex. MEN type 1 (MEN 1), which affects primarily the pituitary, pancreas, and parathyroid glands, is caused by mutations in the menin gene. MEN type 2 (MEN 2) syndromes, MEN 2A and MEN 2B that affect mainly the thyroid and parathyroid glands and the adrenal medulla, and familial medullary thyroid carcinoma (FMTC), are caused by mutations in the RET oncogene. Finally, Carney complex, which affects the adrenal cortex, the pituitary and thyroid glands, and the gonads, is caused by mutations in the gene that codes for regulatory subunit type 1A of protein kinase A (PKA) (PRKAR1A) in at least half of the known patients. Molecular defects have also been identified in syndromes related to the MENs, like Peutz-Jeghers syndrome (PJS) (the STK11/LKB1 gene), and Cowden (CD; the PTEN gene) and von Hippel-Lindau disease (VHLD; the VHL gene). Although recognition of these syndromes at a young age generally improves prognosis, the need for molecular testing in the diagnostic evaluation of the MENs is less clear. This review presents the newest information on the clinical and molecular genetics of the MENs (MEN 1, MEN 2, and Carney complex), including recommendations for genetic screening, and discusses briefly the related syndromes PJS, CD and VHLD.
Similar content being viewed by others
References
Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 1954, 16: 363–371.
Sipple J.H. The association of pheochromocytomas with carcinoma of the thyroid gland. Am. J. Med. 1961, 31: 163–166.
Eng C. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung’s disease. N. Engl. J. Med. 1996, 335: 943–951.
Carney J.A., Gordon H., Carpenter P.C., Shenoy B.V., Go V.L.W. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985, 64: 270–283.
Mulligan L.M., Kwok J.B.J., Healey C.S., Elsdon M.J., Eng C., Gardner E., Love D.R., Mole S.E., Moore J.K., Papi L., Ponder M.A., Telenius H., Tunnacliffe A., Ponder B.A.J. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993, 363: 458–460.
Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A.M., Burns A.L., Marx S.J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997, 276: 404–407.
Kirschner L.S., Carney J.A., Pack S., Taymans S.E., Cho Y.S., Cho-Chung Y., Stratakis C.A. Mutations in the gene encoding the type Ia regulatory subunit of the protein kinase A (PRKARIA) in patients with Carney complex. Nat. Genet. 2000, 26: 89–92.
Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Hoglund P., Jarvinen H., Kristo P., Pelin K., Ridanpaa M., Salovaara R., Toro T., Bodmer W., Olschwang S., Olsen A.S., Stratton M.R., de la Chapelle A., Aaltonen L.A. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998, 391: 184–187.
Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., Muller O., Back W., Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 1998, 18: 38–43.
Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 1997, 16: 64–67.
Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., Stackhouse T., Kuzmin I., Modi W., Geil L., Schmidt L., Zhou F., Li H., Wei M.H., Chen F., Glenn G., Choyke P., McClellan M.W., Weng Y., Duan D.-S.R., Dean M., Glavac D., Richards F.M., Crossey P.A., Ferguson-Smith M.A., Le Paslier D., Chumakov I., Cohen D., Chinault A.C., Maher E.R., Linean W.M., Zbar B., Lerman M.I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260: 1317–1320.
Gagel R.F., Jackson C.E., Ponder B.A.J., Raue F., Simpson N.E., Ziegler R. Multiple endocrine neoplasia type 2 syndromes: Nomenclature recommendations from the workshop organizing committee. Henry Ford Hosp. Med. J. 1989, 37: 99.
Online Mendelian Inheritance in Man, OMIM (TM). Center for Medical Genetics, Johns Hopkins University, and National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, 1999, World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim
Marx S.J., Agarwal S.K., Kester M.B., Heppner C., Kim Y.S., Skarulis M.C., James L.A., Goldsmith P.K., Saggar S.K., Park S.Y., Spiegel A.M., Burns A.L., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Emmert-Buck M.R., Guru S.C., Manickam P., Crabtree J., Erdos M.R., Collins F.S., Chandrasekharappa S.C. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent. Prog. Horm. Res. 1999, 54: 397–438.
Marx S.J. Multiple endocrine neoplasia type 1. In: Bilezikian J.P., Levine M.A., Marcus R. (Eds.), The parathyroids. Raven Press. Ltd., New York, 2000, in press.
Trump D., Farren B., Wooding C., Pang J.T., Besser G.M., Buchanan K.D., Edwards C.R., Eath D.A., Jackson C.E., Jansen C.E., Lips K., Monson J.P., O’Halloran D., Sampson J., Shalet S., Wheeler M.H., Zink A., Thakker R. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q. J. Med. 1996, 89: 653–669.
Vasen H.F., Lamers C.B., Lips C.J. Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands. Arch. Intern. Med. 1989, 149: 2717–2722.
Skarulis M.C., Marx S., Spiegel A. M., Skarulis M.C., Doppman J.L., Collins F.S., Liotta L.A. Multiple endocrine neoplasia type 1: Clinical and genetic topics. Ann. Intern. Med. 1998, 129: 484–494.
Lamers C.B., Froeling P.G. Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I). Am. J. Med. 1979, 66: 422–424.
Marx S.J., Vinik A.I., Santen R.J., Floyd J.C. Jr., Mills J.L., Green J.D. Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred. Medicine (Baltimore) 1986, 65: 226–241.
Ballard H.S., Frame B., Hartsock R.J. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine 1964, 43: 481–516.
Betts J.B., O’Malley B.P., Rosenthal F.D. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1 — Report of a further family and a review of the literature. Q. J. Med. 1980, 49: 69–76.
Scheithauer B.W., Laws E.R. Jr., Kovacs K., Horvath E., Randall R.V., Carney J.A. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin. Diagn. Pathol. 1987, 4: 205–211.
Shepherd J.J. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? Arch. Surg. 1991, 126: 935–952.
O’Brien T., O’Riordan D.S., Gharib H., Scheithauer B.W., Ebersold M.J., van Heerden J.A. Results of treatment of pituitary disease in multiple endocrine neoplasia, type I. Neurosurgery 1996, 39: 273–278; discussion 278–279.
Stratakis C.A., Schussheim D.H., Freedman S.M., Keil M.F., Pack S.D., Agarwal S.M., Skarulis M.C., Weil R.J., Lubensky I.A., Zhuang Z., Oldfield E.H., Marx S.J. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type-1. J. Clin. Endocrinol. Metab. 2000, 85: 4920–4924.
Giraud S., Zhang C.X., Serova-Sinilnikova O., Wautot V., Salandre J., Buisson N., Waterlot C., Bauters C., Porchet N., Aubert J.-P., Emy P., Cadiot G., Delemer B., Chabre O., Niccoli P., Leprat F., Duron F., Emperauger B., Cougard P., Coudet P., Sarfati E., Riou J.-P., Guihard S., Rodier M., Meyrier A., Caron P., Vantyghem M.-C., Assayag M., Peix J.-L., Pugeat M., Rohmer V., Vallotton M., Lenoir G., Gaudray P., Proye C., Conte-Devolx B., Chanson P., Shugart Y.Y., Goldgar D., Murat A., Calender A. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am. J. Hum. Genet. 1997, 63: 455–467.
Thakker R.V. Multiple endocrine neoplasia-syndromes of the twentieth century. J. Clin. Endocrinol. Metab. 1998, 83: 2617–2620.
Gagel R.F. RET protooncogene mutations and endocrine neoplasia — A story intertwined with neural crest differentiation. Endocrinology 1996, 137: 1509–1511.
Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R.F., van Amstel H.K., Lips C.J., Nishisho I., Takai S.I., Marsh D.J., Robinson B.G., Frank-Raue K., Raue F., Xue F., Noll W.W., Romei C., Pacini F., Fink M., Niederle B., Zedenius J., Nordenskjold M., Komminoth P., Hendy G.N., Mulligan L.M. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996, 276: 1575–1579.
Edery P., Eng C., Munnich A., Lyonnet S. RET in human development and oncogenesis. Bioessays 1997, 19: 389–395.
Gagel R.F., Levy M.L., Donovan D.T., Alford B.R., Wheeler T., Tchen J.A. Multiple endocrine neoplasia type 2A associated with cutaneous lichen amyloidosis. Ann. Intern. Med. 1989, 111: 802–806.
Borrego S., Eng C., Sanchez B., Saez M.E., Navarro E., Antinolo G. Molecular analysis of the RET and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. Clin. Endocrinol. Metab. 1998, 83: 3361–3364.
Eng C., Mulligan L.M. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum. Mutat. 1997, 9: 97–109.
Hoff A.O., Cote J., Gagel R.F. Multiple endocrine neoplasias. Annu. Rev. Physiol. 2000, 62: 377–411.
Angrist M., Bolk S., Hallushka M., Lapchak P.A., Chakravarti A. Germline mutations in glial-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat. Genet. 1996, 14: 341–344.
Decker R.A., Peacock M.L., Watson P. Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. Hum. Mol. Genet. 1998, 7: 129–134.
Stratakis C.A. Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. Frontiers Biosc. 2000, 5: d353–366.
Salomon F., Froesh E.R., Hedinger C.E. Familial Cushing syndrome (Carney complex). N. Engl. J. Med. 1990, 322: 1470.
Shenoy B.V., Carpenter P.C., Carney J.A. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am. J. Surg. Pathol. 1984, 8: 335–344.
Schweizer-Cagianut M., Froesch E.R., Hedinger C.E. Familial Cushing’s syndrome with primary adrenocortical microadenomatosis (primary adrenocortical nodular dysplasia). Acta Endocrinol. (Copenh.) 1980, 94: 529–535.
Carney J.A., Hruska L.S., Beauchamp G.D., Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity. Mayo Clin. Proc. 1986, 61: 165–172.
Carney J.A., Young W.F. Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992, 2: 6–21.
Atherton D.J., Pitcher D.W., Wells R.S., Macdonald D.M. A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. Br. J. Dermatol. 1980, 103: 421–429.
Rhodes A.R., Silverman R.A., Harrist T.J., Perez-Atayde A.R. Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: The “LAMB” syndrome. J. Am. Acad. Dermatol. 1984, 10: 72–82.
Carney J.A. Differences between nonfamilial and familial cardiac myxoma. Am. J. Surg. Pathol. 1985, 9: 53–55.
Kennedy R.H., Flanagan J.C., Eagle R.C. Jr., Carney J.A. The Carney complex with ocular signs suggestive of cardiac myxoma. Am. J. Ophthalmol. 1991, 111: 699–702.
Ferreiro J.A., Carney J.A. Myxomas of the external ear and their significance. Am. J. Surg. Pathol. 1994, 18: 274–280.
Carney J.A., Toorkey B.C. Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am. J. Surg. Pathol. 1991, 15: 713–721.
Courcoutsakis N.A., Chow C.K., Shawker T., Carney J.A., Stratakis C.A. Breast imaging findings in the complex of myxomas, spotty pigmentation, endocrine veractivity, and schwannomas (Carney complex). Radiology 1997, 205: 221–227.
Carney J.A., Ferreiro J.A. The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am. J. Surg. Pathol. 1996, 20: 259–272.
Carney J.A. Carney complex: the complex of myxomas, spotty pigmentation, endocrine veractivity, and schwannomas. Semin. Dermatol. 1995, 14: 90–98.
Doppman J.L., Travis W.D., Nieman L., Miller D.L., Chrousos G.P., Gomez T.M., Loriaux D.L. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 1989, 172: 415–420.
Mellinger R.C., Smith R.W. Studies of the adrenal hyperfunction in 2 patients with atypical Cushing’s syndrome. J. Clin. Endocrinol. Metab. 1955, 16: 350–366.
Kracht J., Tamm J. Bilaterale kleiknotige Adenomatose der Nebennierenrinde bei Cushing-Syndrom. Virchows Arch. Path. Anat. 1960, 333: 1–9.
Levin M.E. The development of bilateral adenomatous adrenal hyperplasia in a case of Cushing’s syndrome of eighteen years’ duration. Am. J. Med. 1966, 40: 318–324.
De Moor P., Roels H., Delaere K., Crabbe J. Unusual case of adrenocortical hyperfunction. J. Clin. Endocrinol. Metab. 1965, 25: 612–620.
Sarlis N.J., Chrousos G.P., Doppman J.L., Carney J.A., Stratakis C.A. Primary pigmented nodular adrenocortical disease (PPNAD): re-evaluation of a patient with Carney complex 27 years after unilateral adrenalectomy. J. Clin. Endocrinol. Metab. 1997, 82: 2037–2043.
Gomez-Muguruza M.T., Chrousos G.P. Periodic Cushing’s syndrome in a short boy: usefulness of the ovine corticotropin releasing hormone test. J. Pediatr. 1989, 115: 270–273.
Stratakis C.A., Sarlis N.J., Kirschner L.S., Carney J.A., Doppman J.L., Chrousos G.P., Papanicolaou D.A. Paradoxical response to dexamethasone assists with the diagnosis of primary pigmented nodular adrenocortical disease (PPNAD). Ann. Intern. Med 1999, 131: 585–591.
Watson J.C., Stratakis C.A., Bryant-Greenwood P.K., Koch C.A., Kirschner L.S., Nguyen T., Carney J.A., Oldfield E.H. Neurosurgical implications of Carney complex. J. Neurosurg. 2000, 92: 413–418.
Raff S.B., Carney J.A., Krugman D., Doppman J.L., Stratakis C.A. Prolactin secretion abnormalities in patients with the “syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas” (Carney complex). J. Pediatr. Endocrinol. Metab. 2000, 13: 373–379.
Pack S., Kirshner L.S., Pak E., Carney J.A., Zhuang Z., Stratakis C.A. Pituitary tumors in patients with the “complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas” (Carney complex): evidence for progression from somatomammotroph hyperplasia to adenoma. J. Clin. Endocrinol. Metab. 2000, 85: 3860–3865.
Premkumar A., Stratakis C.A., Shawker T.H., Papanicolaou D.A., Chrousos G.P. Testicular ultrasound in Carney complex. J. Clin. Ultrasound 1997, 25: 211–214.
Stratakis C.A., Papageorgiou T., Premkumar A., Kirschner L.S., Taymans S.E., Pack S., Zhuang Z., Oelkers W.H., Carney J.A. Ovarian cysts in patients with Carney complex: clinical and genetic studies and evidence for predisposition to cancer. J. Clin. Endocrinol. Metab. 2000, 85: 4359–4366.
Carney J.A. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am. J. Surg. Pathol. 1990, 14: 206–222.
Carney J.A., Toorkey B.C. Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Am. J. Surg. Pathol. 1991, 15: 722–731.
Carney J.A., Stratakis C.A. Ductal adenoma of the breast. Am. J. Surg. Pathol. 1996, 20: 1154–1155.
Stratakis C.A., Courcoutsakis N., Abati A., Filie A., Doppman J.L., Carney J.A., Shawker T.H. Thyroid gland abnormalities in patients with the “syndrome of spotty skin pigmentation, myxomas, and endocrine overactivity” (Carney complex). J. Clin. Endocrinol. Metab. 1997, 82: 2037–2043.
Stratakis C.A., Carney J.A., Lin J.-P., Papanicolaou D.A., Karl M., Kastner D.L., Pras E., Chrousos G.P. Carney Complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J. Clin. Invest. 1996, 97: 699–705.
Casey M., Mah C., Merliss A.D., Kirschner L.S., Taymans S.E., Denio A.E., Korf B., Irvine A.D., Hughes A., Carney J.A., Stratakis C.A., Basson C.T. Identification of a novel genetic locus for familial cardiac myxomas and Carney Complex. Circulation 1998, 98: 2560–2566.
Stratakis C.A., Pras E., Lin J.-P., Kastner D.L., Carney J.A., Chrousos G.P. Carney complex, a multiple endocrine neoplasia and familial lentiginosis syndrome: clinical analysis and linkage to the D2S123 locus (chromosome 2p16). Am. J. Hum. Genet. 1995, 57: A54.
Dewald G.W., Dahl R.J., Spurbeck J.L., Carney J.A., Gordon H. Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin. Proc. 1987, 62: 558–567.
Dijkhuizen T., van der Derg E., Molenaar W.M., Meuzelaar J.J., de Jong B. Cytogenetics of a case of cardiac myxoma. Cancer Genet. Cytogenet. 1992, 63: 73–75.
Richkind K.E., Wason D., Vidaillet H.J. Cardiac myxoma characterized by clonal telomeric association. Genes Chrom. Cancer 1994, 9: 68–71.
Stratakis C.A., Jenkins R.B., Pras E., Mitsiades C.S., Raff S.B., Stalboerger P., Tsigos C., Carney J.A., Chrousos G.P. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J. Clin. Endocrinol. Metab. 1996, 81: 3607–3614.
Takai S., Iwama T., Tonomura A. Chromosome instability in cultured skin fibroblasts from patients with familial polyposis coli and Peutz-Jeghers syndrome. Jpn. J. Cancer Res. 1986, 77: 759–766.
Griffin C.A., Lazar S., Hamilton S.R., Giardello F.M., Long P., Krush A.J. Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenomas. Cancer Genet. Cytogenet. 1993, 67: 14–20.
Richard F., Muleris M., Dutrillaux B. Chromosome instability in lymphocytes from patients affected by or genetically predisposed to colorectal cancer. Cancer Genet. Cytogenet. 1994, 73: 23–32.
DeMarco L., Stratakis C.A., Boson W.L., Yakbovitz O., Carson E., Adrade L.M., Chrousos G.P., Nordenskjold M., Friedman E. Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gsα gene. Hum. Genet. 1996, 98: 185–188.
Basson C.T., MacRae C.A., Korf B., Merliss A. Genetic heterogeneity of familial atrial myxoma syndromes (Carney Complex). Am. J. Cardiol. 1997, 79: 994–995.
Taymans S.E., Macrae C.A., Casey M., Merliss A., Lin J.-P., Rocchi M., Kirschner L.S., Basson C.T., Stratakis C.A. A refined genetic, radiation hybrid, and physical map of the Carney complex (CNC) locus on chromosome 2p16; evidence for genetic heterogeneity in the syndrome. Am. J. Hum. Genet. 1997, 61: A84.
Scott J.D. Cyclic nucleotide-dependent protein kinases. Pharmac. Ther. 1991, 50: 123–145.
Kirschner L.S., Sandrini F., Monbo J., Carney J.A., Stratakis C.A. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum. Mol. Genet. 2000, 9: 3037–3046.
Taymans S.E., Kirschner L.S., Pack S., Ping Z., Stratakis C.A. YAC-BAC contig of the Carney complex (CNC) critical region on 2p16 and copy number gain of 2p16 in CNC tumors: evidence for a novel oncogene? Am. J. Hum. Genet. 1999, 65: A326.
Stratakis C.A., Kirschner L.S., Taymans S.E., Tomlinson I.P.M., Marsh D.J., Torpy D.J., Giatzakis C., Eccles D.M., Theaker J., Houlston R.S., Blouin J.-L., Antonarakis S.E., Basson C.T., Eng C., Carney J.A. Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J. Clin. Endocrinol. Metab. 1998, 83: 2972–2976.
Peutz J.L.A. Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentation of skin and mucous membrane. Nederl. Maandschr. Geneesk. 1921, 10: 134–146.
Jeghers H., McKusick V.A., Katz K.H. Generalised intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N. Engl. J. Med. 1949, 241: 993–1005; 1031–1036.
Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell. Mol. Life Sci. 1999, 55: 735–750.
Hemminki A., Tomlinson I., Markie D., Järvinen H., Sistonen P., Bjorkqvist A.-M., Knuutila S., Salovaara R., Bodmer W., Shibata D., de la Chapelle A., Aaltonen L.A. Localisation of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridisation and targeted linkage analysis. Nat. Genet. 1997, 15: 87–90.
Boardman L.A., Thibodeau S.N., Schaid D.J., Lindor N.M., McDonnell S.K., Burgart L.J., Ahlquist D.A., Podratz K.C., Pittelkow M., Hartmann L.C. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann. Intern. Med. 1998, 128: 896–899.
Westerman A.M., Wilson J.H.P. Peutz-Jeghers syndrome: Risks of a hereditary condition. A clinical review. Scand. J. Gastroenterol. 1999, 230: 64–70.
Giardello F.M., Welsh S.B., Hamilton S.R., Offerhaus G.J.A., Gittelsohn A.M., Booker S.V. Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med. 1987, 316: 1511–1514.
Hizawa K., Iida M., Matsumoto T., Kohrogi N., Kinoshita H., Yao T. Cancer in Peutz-Jeghers syndrome. Cancer 1993, 72: 2777–2781.
Foley T.R., McGarrity T.J., Abt A.B. Peutz-Jeghers syndrome: a clinicopathologic survey of the “Harrisburg family” with a 49-year follow up. Gastroenterology 1988, 95: 1535–1540.
Rustgi A.K. Hereditary gastrointestinal polyposis and non-polyposis syndromes. N. Engl. J. Med. 1994, 331: 1694–1702.
Spigelman A.D., Murday V., Phillips R.K.S. Cancer and Peutz-Jeghers syndrome. Gut 1989, 30: 1588–1590.
Pathomvanich A., Koch C., Stratakis C.A. Thyroid abnormalities in Peutz-Jeghers syndrome: Report of new observation and review of the literature. J. Endocr. Genet. 1999, 1: 47–49.
Young R.H., Scully R.E. Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix: clinicopathologic analysis of 16 cases. Int. J. Gynecol. Pathol. 1988, 7: 99–111.
Young R.H., Welch W.R., Dickersin G.E., Scully R.E. Ovarian sex stromal tumor with annular tubules; review of 74 cases including 27 with Peutz-Jeghers syndrome and 4 with adenoma malignum of the cervix. Cancer 1982, 50: 1384–1402.
Young S., Gooneratne S., Straus F.H., Zeller W.P., Bulun S.E., Rosenthal I.M. Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome. Am. J. Surg. Pathol. 1995, 19: 50–58.
Markie D., Huson S., Maher E., Davies A., Tomlison I., Bodmer W.F. A pericentric inversion of chromosome 6 in a patient with Peutz-Jeghers syndrome and the use of FISH to localize the breakpoints on a genetic map. Hum. Genet. 1996, 98: 125–128.
Bali D., Gourley I.S., McGarrity T.J., Spencer C.A., Howard L., Frazier M.L., Amos C. Peutz-Jeghers syndrome maps to chromosome 1p. Am. J. Hum. Genet. 1995, 57: A186.
Tomlinson I.P.M., Olschwang S., Abelovitch D., Nakamura Y., Bodmer W.F., Thomas G., Markie D. Testing candidate loci on chromosomes 1 and 6 for genetic linkage to Peutz-Jegher’s disease. Ann. Hum. Genet. 1996, 60: 377–384.
Olschwang S., Markie D., Seal S., Neale K., Phillips R., Cottrell S., Ellis I., Hodgson S., Zauber P., Spigelman A., Iwama T., Loff S., McKeown C., Marchese C., Sampson J., Davies S., Talbot I., Wyke J., Thomas G., Bodmer W., Hemminki A., Avizienyte E., de la Chapelle A., Aaltonen L., Stratton M., Houlston R., Tomlinson I. Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J. Med. Genet. 1998, 35: 42–44.
Mehenni H., Blouin J.-L., Radhakrishna U., Bhardwaj S.S., Bhardwaj K., Dixit V.B., Richards K.F., Bermejo-Fenoll A., Leal A.S., Raval R.C., Antonarakis S.E. Peutz-Jeghers syndrome: Confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am. J. Hum. Genet. 1997, 61: 1327–1334.
Westerman A.M., Entius M.M., Boor P.P.C., Koole R., de Baar E., Offerhaus G.J.A., Lubinski J., Lindhout D., Halley D.J.J., de Rooij F.W.M., Wilson J.H.P. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum. Mutat. 1999, 13: 476–481.
Wang Z.-J., Churchman M., Avizienyte E., McKeown C., Davies S., Evans D.G.R., Ferguson A., Ellis I., Xu W.-H., Yan Z.-Y., Aaltonen L.A., Tomlinson I.P.M. Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. J. Med. Genet. 1999, 36: 365–368.
Resta N., Simone C., Mareni C., Montera M., Gentile M., Susca F., Gristina R., Pozzi S., Bertario L., Bufo P., Carlomagno N., Ingrosso M., Rossini F.P., Tenconi R., Guanti G. STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res. 1998, 58: 4799–4801.
Jiang C.-Y., Esufali S., Berk T., Gallinger S., Cohen Z., Tobi M., Redston M., Bapat B. STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clin. Genet. 1999, 56: 136–141.
Ylikorkala A., Avizienyte E., Tomlinson I.P.M., Tiainen M., Roth S., Loukola A., Hemminki A., Johansson M., Sistonen P., Markie D., Neale K., Phillips R., Zauber P., Twama T., Sampson J., Järvinen H., Mäkelä T.P., Aaltonen L.A. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum. Mol. Genet. 1999, 8: 45–51.
Boardman L.A., Couch F.J., Burgart L.J., Schwartz D., Berry R., McDonnell S.K., Schaid D.J., Hartmann L.C., Schroeder J.J., Stratakis C.A., Thibodeau S.N. Genetic heterogeneity in Peutz-Jeghers syndrome. Hum. Mutat. 2000, 16: 23–30.
Su J.-Y., Erikson E., Maller J.L. Cloning and characterisation of a novel serine/threonine protein kinase expressed in early Xenopus embryos. J. Biol. Chem. 1996, 271: 14430–14437.
Smith D.P., Spicer J., Smith A., Swift S., Ashworth A. The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase. Hum. Mol. Genet. 1999, 8: 1479–1485.
Mehenni H., Gehrig C., Nezu J., Oku A., Shimane M., Rossier C., Guex N., Blouin J.-L., Scott H.S., Antonarakis S.E. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am. J. Hum. Genet. 1998, 63: 1641–1650.
Nelen M.R., Padberg G.W., Peeters E.A.J., Lin A.Y., van den Helm B., Frants R.R., Coulon V., Goldstein A.M., van Reen M.M.M., Easton D.F., Eeles R.A., Hodgson S., Mulvihill J.J., Murday V.A., Tucker M.A., Mariman E.C.M., Starink T.M., Ponder B.A.J., Ropers H.H., Kremer H., Longy M., Eng C. Localization of the gene for Cowden disease to chromosome 10q22–23. Nat. Genet. 1996, 13: 114–116.
Eng C. Genetics of Cowden syndrome: Through the looking glass of oncology. Int. J. Oncol. 1998, 12: 701–710.
Nelen M.R., van Staveren W.C.G., Peeters E.A.J., Hassel M.B., Gorlin R.J., Hamm H., Lindboe C.F., Fryns J.-P., Sijmons R.H., Woods D.G., Mariman E.C.M., Padberg G.W., Kremer H. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet. 1997, 6: 1383–1387.
Marsh D.J., Kum J.B., Lunetta K.L., Bennett M.J., Gorlin R.J., Ahmed S.F., Bodurtha J., Crowe C., Curtis M.A., Dasouki M., Dunn T., Feit H., Geraghty M.T., Graham J.M., Hodgson S.V., Hunter A., Korf B.R., Manchester D., Miesfeldt S., Murday V.A., Nathanson K.L., Parisi M., Pober B., Romano C., Tolmie J.L., Trembath R., Winter R.M., Zackai E.H., Zori R.T., Weng L.-P., Dahia P.L.M., Eng C. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 1999, 8: 1461–1472.
Longy M., Coulon V., Duboue B., David A., Larregue M., Eng C., Amati P., Kraimps J.-L., Bottani A., Lacombe D., Bonneau D. Mutations of PTEN in patients with Bannayan-Riley-Ruvalacaba phenotype. J. Med. Genet. 1998, 35: 886–889.
Linehan W.M., Lerman M.I., Zbar B. Identification of the von Hippel-Lindau (VHL) gene. JAMA 1995, 273: 564–570.
Richards F.M., Webster A.R., McMahon R., Woodward E.R., Rose S., Maher E.R. Molecular genetic analysis of von Hippel-Lindau disease. J. Intern. Med. 1998, 243: 527–533.
Bar M., Friedman E., Jakobovitz O., Leibowitz G., Lerer I., Abeliovich D., Gross D.J. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes. Clin. Endocrinol. (Oxf.) 1997, 47: 707–712.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stratakis, C.A. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest 24, 370–383 (2001). https://doi.org/10.1007/BF03343875
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343875